1. PeterWiklund, Department of Urology, Karolinska University Hospital, SE-17176, Stockholm, Sweden2. KariHeminki, GermanCancerResearchCenter. Molecular and Genetic Epidemiology of Cancer. 3. JesperLagergren, Karolinska Institute, stomachandesophagealcancer, Sweden4. ClaesGustafsson, Univer1. Visiting professor allowance is RMB 10000 to 15000 per person per month, paid based on actual working hours. The performance allowance shall be paid by the research group (or department, hospital) based on the approved project or project situation. 2. Provide temporary housing for free. 3. Provide necessary laboratory and office space. 4. Provide round-trip travel expenses to our hospital every year according to work needs.

1. Professor Torsten Mueller, Hohenheim University, Germany. Mainly conducting research on the optimization of phosphorus resources in the grain feed energy system, mainly based on corn. 2. Jean Beigbeder, a French maize breeding expert. He has worked in corn breeding related fields at internationally renowned seed companies such as Lima Grande Seed Company in France, Pioneer Seed Company in the United States, and Syngenta Seed Company, and has a wealth of corn breeding theory and experience. Please come to our company, Jean Beigbeder, to tell us about the three major temperate corn belts in the world: the United States, Europe, and China, with illustrations and text. And based on this, the differences in the correlation between corn maturity, rainfall, yield and other factors in three places were analyzed. Taking major international seed companies as examples, we clearly identified the reasons for the differences. Combined with the current situation of corn breeding in Europe, and facing the competitive pressure of the global seed industry market, we pointed out China's corn breeding strategy and technical route. 3. Dr. Joachim Kramer, an Austrian maize breeding expert. Dr. Joachim Kramer has been engaged in research on maize breeding for a long time. I worked at a German seed company from 1971 to 1986, and then at Pioneer in the United States for 23 years, with extensive experience in maize breeding. He proposed future breeding directions: breeding new maize varieties with high yield, high density tolerance, lodging resistance, disease resistance, fast grain dehydration rate, and suitability for mechanized grain harvesting. At the same time, Dr. Joachim Kramer made a profound analysis and explanation on the improvement and innovation of germplasm resources, especially on the introduction of foreign maize germplasm from Europe and the United States. He invited him to China, and would certainly put forward good suggestions and opinions on China's maize breeding, especially our company's maize breeding, and asked him to tell us about the improvement methods of inbred lines with good traits, parent selection of strong heterosis combinations Conservation and utilization of germplasm resources in Europe and the United States. Further improve the theoretical level of maize breeding in China and accelerate the process of maize breeding.

The First Hospital of Hebei Medical University has established a dedicated office with one permanent staff member, whose job responsibilities include scientific research coordination, technical guidance services, and daily reception. Responsible for liaising and ensuring work. Funds are allocated annually for workstation research, clinical operation, and management. A dedicated person is responsible for the accommodation, itinerary, and domestic arrangements of foreign experts.

1. Has a strong sense of professionalism and dedication, adheres to academic ethics, has a correct academic style, rigorous academic research, and has good personal qualities and medical ethics. 2. Has strategic thinking and profound academic expertise in the field of psychological counseling and treatment, with significant academic influence in the international academic community. 3. Experts and scholars who hold senior professional and technical positions in psychological counseling and treatment in renowned foreign universities and research institutes. 4. They have solid theoretical foundation, exquisite business skills, and strong business training abilities. 5. Provide accommodation for physical health and ensure that the salary level is not lower than that of Germany during the same period.

In recent years, our company has actively introduced international professional talents to form a dedicated team to prepare for the EU GMP certification. We successfully passed the EU certification on-site audit in July 2018 and obtained the EU GMP certification certificate in November 2019. In September 2017, Dutch expert Marco Albada Jelgersma was hired as the EU quality auditor. Mr. Marco is a senior pharmacist and EU regulatory consultant in the EU. Mr. Marco carefully understands the current production status, laboratory experiments, GMP document writing progress, and provides technical services and professional technical guidance for the accuracy, timeliness, and completeness of our company's production, operation, and confirmation. In September 2017, Dr. Fang, an American expert who was a former FDA auditor and had extensive experience in GMP in the United States and the European Union, was introduced. After many communications, the expert conducted a gap analysis on the current situation of our company and American and European standards, comprehensively and systematically evaluated the GMP work preparation, proposed the assessment of the problems and defects in the current work, and proposed the implementation plan to improve and strengthen GMP management in the future, so as to promote our company to pass the EU certification successfully. In April 2018, in order to ensure the smooth passage of the EU official audit, LUCIANOMASSIANTONIO was hired to conduct a phased work audit. This audit was conducted in full accordance with the requirements of on-site GMP inspections in Europe and America, recording the compliance of personnel with the implementation of GMP regulations in Europe and America under various dynamic conditions. At the same time, conduct in-depth and detailed checks on the compliance of current GMP documents and records in different modules. The expert clearly stated that at the current level, our company's software and hardware have basically met the GMP requirements of the European Union and FDA, strengthening our confidence in passing the official on-site audit of the European Union at once. In July 2018, JOANNAEWAMANIA was hired as our company's EU quality auditor. She is a senior pharmaceutical consultant in the EU. Through this consulting work, we will confirm that the project meets EU regulatory requirements and welcome the formal on-site audit. She went deep into the workshop and pointed out the existing problems and areas for improvement. In terms of product registration in Europe, we also carefully explain the requirements of EU regulations. JOANNA's attitude of striving for excellence has left a deep impression on our employees and reflects the severity of the drug production process in EU countries. From July 16th to 20th, 2018, our company received a 5-day rigorous and meticulous inspection of the software and hardware systems by the Portuguese official GMP prosecutor. The four prosecutors unanimously believed that our company's quality management system was sound and had met the inspection requirements for EU GMP certification. In November 2019, Italian experts ANGELOCONSOLARO and BRUNOXOMPERO were introduced. These two experts have years of development experience in the field of blowing, filling, and sealing equipment. Through multiple communications and exchanges, as well as on-site guidance and careful training for our company's technical personnel, they conducted in-depth and detailed inspections in modules, enabling our company's technical personnel to grasp the operation of the equipment. The expected results have been achieved, and the software and hardware aspects of the device have been further improved. In the future, our company will continue to implement talent introduction projects, introduce foreign experts, guide and promote the entry of anti-tumor drug products into the international market.

R&D Director

October, 1978 to October, 1980, studied in Xingtai Finance and Trade School October, 1980 to December, 1992, Deputy Manager and General Accountant of Weixian Local Products Company December, 1992 to December, 1995, General Manager of Weixian United Purchase and Marketing Company December, 1995 to May, 2002, General Manager of Weixian Agricultural means of production General Company May, 2002 to August, 2005, General Manager of Xingtai Weiyuan Agricultural Means of Production Group Co., Ltd. August, 2005 to December, 2010, Chairman of Hebei Yuanda International Fertilizer Co., Ltd From December 2010 to present, the Chairman and General Manager of Genlido Biotechnology Co., Ltd. plan to introduce experts and technologies from the San Joaquin Valley Agricultural Science Center of the US Department of Agriculture Research Institute and the Plant Health Laboratory of the Alberta Department of Agriculture and Forestry in Canada. The main technical requirements for introducing the US Department of Agriculture laboratory are related technologies for microbial improvement of saline soil, and improving the product development and technical level of Genlido Co., Ltd. in microbial soil amendments. The main technical requirements for introducing the Alberta Plant Health Laboratory in Canada are related technologies for using microbial fertilizers to improve plant resistance to drought, salinity, diseases and pests, Enhance the product development and technical level of Genliduo Co., Ltd. in the field of microbial plant inducers.

Doctor degree or above, major in pharmacy. Presided over the whole process of injection research and development. He has experience in management of injection R&D team in large European and American pharmaceutical enterprises. Provide a two-bedroom and one-hall hotel apartment as a dormitory, with excellent salary.

In recent years, our company has actively introduced international professionals to form a special team to prepare for the EU GMP certification, successfully passed the EU certification on-site audit in July 2018, and successfully obtained the EU GMP certification certificate in November 2019. In September 2017, the Dutch expert Marco Albada Jelgersma was hired as the EU quality releaser. Mr. Marco is a senior pharmacist in the EU and the EU regulation consultant. Mr. Marco carefully understood the current production situation, the laboratory experiment progress, and the preparation progress of GMP documents, providing technical services and professional technical guidance for the accuracy, timeliness and completeness of our company's production, operation and confirmation. In September 2017, Dr. Fang, an American expert who is a former FDA auditor and has rich experience in GMP in the United States and the European Union, was introduced. After many communications, the expert analyzed the gap between the current situation of our company and the standards of the United States and Europe, comprehensively and systematically evaluated the preparation of GMP work, put forward the evaluation of the problems and defects in the current work, and put forward the implementation plan to improve and strengthen the GMP management in the future period, so as to promote our company to successfully pass the EU certification. In April 2018, in order to ensure the smooth passing of the official audit of the EU, LUCIANO MASCIANTONIO was specially hired to conduct a phased work audit. This audit was conducted in full accordance with the requirements of on-site inspection of GMP in Europe and the United States, recording the compliance of personnel with the implementation of GMP regulations in Europe and the United States under various dynamic conditions. At the same time, the compliance of current GMP documents and records will be checked in depth and detail by module. The expert clearly stated that at the current level, our company's software and hardware have basically met the requirements of the European Union and FDA for GMP, which has strengthened our confidence in passing the official on-site audit of the European Union at one time. In July 2018, JOANNA EWA MANIA was hired as the EU quality release agent of our company. She is a senior drug consultant in the EU. Through this consultation, we will confirm that the project has been able to meet the requirements of EU regulations, so as to meet the formal on-site audit. She went into the workshop and pointed out the existing problems and areas for improvement. In terms of product registration in Europe, we also carefully explained the requirements of EU regulations. JOANNA's work attitude of keeping improving has left a deep impression on our employees, and also reflects the severity of the drug production process in EU countries. From July 16 to 20, 2018, our company welcomed the strict and meticulous acceptance of the software and hardware system by the Portuguese official GMP prosecutor for five days. 4. The prosecutor agreed that our company's quality management system is sound and has met the inspection requirements of the EU GMP certification. In November 2019, Italian experts ANGELO CONSOLARO and BRUNO XOMPERO were introduced. The above two experts have many years of development experience in the field of blowing, filling and sealing equipment. Through many communications and exchanges, as well as on-site guidance and careful training for our company's technical personnel, in-depth and detailed inspection was carried out by modules to enable our company's technical personnel to master the operation of the equipment. The expected results have been achieved, and the equipment software and hardware have been further improved. In the future, our company will continue to implement the project of introducing talents, introduce foreign experts, guide and promote the entry of anti-tumor drugs into the international market.